CD276 and neoplasm: Moreover, CD276 enhanced the angiogenic function of tumor-associated macrophages, and CD276-blocking antibody raised the therapeutic efficiency of paclitaxel /anti-PD-1 in 4T1 tumor-bearing mice (Cheng et al., 2021).